These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 37857825)

  • 1. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease.
    Liu CC; Wang N; Chen Y; Inoue Y; Shue F; Ren Y; Wang M; Qiao W; Ikezu TC; Li Z; Zhao J; Martens Y; Doss SV; Rosenberg CL; Jeevaratnam S; Jia L; Raulin AC; Qi F; Zhu Y; Alnobani A; Knight J; Chen Y; Linares C; Kurti A; Fryer JD; Zhang B; Wu LJ; Kim BYS; Bu G
    Nat Immunol; 2023 Nov; 24(11):1854-1866. PubMed ID: 37857825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.
    Stephen TL; Cacciottolo M; Balu D; Morgan TE; LaDu MJ; Finch CE; Pike CJ
    Acta Neuropathol Commun; 2019 May; 7(1):82. PubMed ID: 31113487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
    Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
    Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE
    J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.
    Liu CC; Zhao J; Fu Y; Inoue Y; Ren Y; Chen Y; Doss SV; Shue F; Jeevaratnam S; Bastea L; Wang N; Martens YA; Qiao W; Wang M; Zhao N; Jia L; Yamazaki Y; Yamazaki A; Rosenberg CL; Wang Z; Kong D; Li Z; Kuchenbecker LA; Trottier ZA; Felton L; Rogers J; Quicksall ZS; Linares C; Knight J; Chen Y; Kurti A; Kanekiyo T; Fryer JD; Asmann YW; Storz P; Wang X; Peng J; Zhang B; Kim BYS; Bu G
    Nat Neurosci; 2022 Aug; 25(8):1020-1033. PubMed ID: 35915180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12.
    Sepulveda J; Kim JY; Binder J; Vicini S; Rebeck GW
    Mol Neurodegener; 2024 Mar; 19(1):24. PubMed ID: 38468308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner.
    Wong MY; Lewis M; Doherty JJ; Shi Y; Cashikar AG; Amelianchik A; Tymchuk S; Sullivan PM; Qian M; Covey DF; Petsko GA; Holtzman DM; Paul SM; Luo W
    J Neuroinflammation; 2020 Jun; 17(1):192. PubMed ID: 32552741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease.
    Fitz NF; Nam KN; Wolfe CM; Letronne F; Playso BE; Iordanova BE; Kozai TDY; Biedrzycki RJ; Kagan VE; Tyurina YY; Han X; Lefterov I; Koldamova R
    Nat Commun; 2021 Jun; 12(1):3416. PubMed ID: 34099706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial APOE4: more is less and less is more.
    Eskandari-Sedighi G; Blurton-Jones M
    Mol Neurodegener; 2023 Dec; 18(1):99. PubMed ID: 38115077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.
    Najm R; Zalocusky KA; Zilberter M; Yoon SY; Hao Y; Koutsodendris N; Nelson M; Rao A; Taubes A; Jones EA; Huang Y
    Cell Rep; 2020 Jul; 32(4):107962. PubMed ID: 32726626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
    Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
    Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
    Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
    Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
    J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination.
    Wang N; Wang M; Jeevaratnam S; Rosenberg C; Ikezu TC; Shue F; Doss SV; Alnobani A; Martens YA; Wren M; Asmann YW; Zhang B; Bu G; Liu CC
    Mol Neurodegener; 2022 Nov; 17(1):75. PubMed ID: 36419137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.
    Liao F; Li A; Xiong M; Bien-Ly N; Jiang H; Zhang Y; Finn MB; Hoyle R; Keyser J; Lefton KB; Robinson GO; Serrano JR; Silverman AP; Guo JL; Getz J; Henne K; Leyns CE; Gallardo G; Ulrich JD; Sullivan PM; Lerner EP; Hudry E; Sweeney ZK; Dennis MS; Hyman BT; Watts RJ; Holtzman DM
    J Clin Invest; 2018 May; 128(5):2144-2155. PubMed ID: 29600961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE genotype-specific differences in the innate immune response.
    Vitek MP; Brown CM; Colton CA
    Neurobiol Aging; 2009 Sep; 30(9):1350-60. PubMed ID: 18155324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.